摘要
背景:由于目前使用的治疗剂的非特异性细胞毒活性,癌症化疗受到严重副作用的限制。为了尽量减少这些不必要的影响,已经采取了几种方法,依靠使用光来激活药物。由于光能够以非常高的时空分辨率传递,该技术是在其作用部位选择性激活细胞毒性药物并由此提高化疗的耐受性和安全性的有前景的策略。 目的:本综述总结了不同的光化学疗法的方法,并确定其挑战和机遇。 结果:根据各自的光疗指数和活化所需的波长对各篇论文进行总结和评估。首先描述了包括铂 - ,钌 - 和铑 - 配合物的光活化金属配合物的设计,合成和/或评价。接下来,报道了光学金属配合物和光敏有机化学治疗剂,具有广泛的细胞毒性机制。最后一部分包括用于癌症治疗的光敏药物的例子。 _一些设计,特别是金属络合物,由于其非常高的光治疗指数(> 1880)而突出,但是光响应性金属络合物和有机化学治疗剂的共同缺点是活化的不可逆性。然而,照片可切换的药物解决了这个挑战。尽管如此,紫外线对其激活的需求仍然限制了它们的应用。 结论:光敏化癌症化学疗法领域正在快速发展,已经包含了非常有前途的方法,其设计提供了高度的光治疗指数,并且还包括NIR或可见光活化的药物。
关键词: 光活化,癌症,化学疗法,光照,金属络合物,光药理学。
Current Medicinal Chemistry
Title:Beyond Photodynamic Therapy: Light-Activated Cancer Chemotherapy
Volume: 24 Issue: 42
关键词: 光活化,癌症,化学疗法,光照,金属络合物,光药理学。
摘要: Background: Cancer chemotherapy is limited by severe side effects due to unspecific cytotoxic activity of currently used therapeutics. In order to minimize these unwanted effects, several approaches have been taken, relying on the use of light to activate drugs. As light can be delivered with a very high spatiotemporal resolution, this technique is a promising strategy to selectively activate cytotoxic drugs at their site of action and thus to improve the tolerability and safety of chemotherapy.
Objective: This review summarizes different approaches towards photoactivated chemotherapy and identifies its challenges and opportunities.
Results: The respective papers were summarized and evaluated in terms of their phototherapeutic indices and the wavelength needed for activation. First, the design, synthesis and/or evaluation of photoactivated metal complexes including platinum- , ruthenium-, and rhodium-complexes is described. Next, photocaged metal complexes and photoacaged organic chemotherapeutics are reported, with a wide range of cytotoxicity mechanisms. The final part includes, examples of photoswitchable drugs for cancer therapy.
Some designs, especially metal complexes, stand out due to their very high phototherapeutic index (> 1880) but the common drawback of light-responsive metal complexes and organic chemotherapeutics is the irreversibility of activation. Photoswitchable drugs, however, address this challenge. Nevertheless, the need of UV light for their activation still limits their application.
Conclusion: The field of photoactivated cancer chemotherapy is rapidly growing and already includes very promising approaches with designs providing high phototherapeutic indices and also NIR or visible light-activatable drugs.
Export Options
About this article
Cite this article as:
Beyond Photodynamic Therapy: Light-Activated Cancer Chemotherapy, Current Medicinal Chemistry 2017; 24 (42) . https://dx.doi.org/10.2174/0929867323666160906103223
DOI https://dx.doi.org/10.2174/0929867323666160906103223 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Comparison of the Structure and Biological Activities of Wild-type and Mutant Liver-targeting Peptide Modified Recombinant Human Endostatin (rES-CSP) in Human Hepatocellular Carcinoma HepG2 Cells
Protein & Peptide Letters p53: Fighting Cancer
Current Cancer Drug Targets Epivention: Epigenetic Based Cancer Chemoprevention
Epigenetic Diagnosis & Therapy (Discontinued) Fluorescent Carbon Dots and Nanodiamonds for Biological Imaging: Preparation, Application, Pharmacokinetics and Toxicity
Current Drug Metabolism Aloperine Induces Apoptosis by a Reactive Oxygen Species Activation Mechanism in Human Ovarian Cancer Cells
Protein & Peptide Letters Current Genome Editing Tools in Gene Therapy: New Approaches to Treat Cancer
Current Gene Therapy Study of Cancer Cell Lines with Fourier Transform Infrared (FTIR)/ Vibrational Absorption (VA) Spectroscopy
Current Physical Chemistry Labeling Polyamidoamine (PAMAM) Dendrimers with Technetium-99m via Hydrazinonicotinamide (HYNIC)
Current Radiopharmaceuticals Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma
Current Cancer Drug Targets Molecular Recognition at Purine and Pyrimidine Nucleotide (P2) Receptors
Current Topics in Medicinal Chemistry Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug
Inflammation & Allergy - Drug Targets (Discontinued) Interactive Effect of Cigarette Smoking and Gene Variants for Predisposing to Cardiovascular Disease
Current Pharmaceutical Design Non-invasive Biodiversified Sensors: A Modernized Screening Technology for Cancer
Current Pharmaceutical Design Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Transcriptionally Targeted Adenovirus Vectors
Current Gene Therapy A Rationalized Approach to Design and Discover Novel Non-steroidal Derivatives through Computational Aid for the Treatment of Prostate Cancer
Current Computer-Aided Drug Design Melatonin Attenuates Methamphetamine-Induced Neurotoxicity
Current Pharmaceutical Design A hypothesis for the role of RECK in angiogenesis
Current Vascular Pharmacology Vitamin D Metabolites and/or Analogs: Which D for Which Patient?
Current Vascular Pharmacology Targeting Ras-RAF-ERK and its Interactive Pathways as a Novel Therapy for Malignant Gliomas
Current Cancer Drug Targets